vs
Esperion Therapeutics, Inc.（ESPR）与Kodiak Gas Services, Inc.（KGS）财务数据对比。点击上方公司名可切换其他公司
Kodiak Gas Services, Inc.的季度营收约是Esperion Therapeutics, Inc.的2.0倍（$332.9M vs $168.4M），Esperion Therapeutics, Inc.同比增速更快（143.7% vs 7.5%），过去两年Kodiak Gas Services, Inc.的营收复合增速更高（24.3% vs 10.6%）
Esperion Therapeutics, Inc.是一家上市美国药企，专注开发用于降低低密度脂蛋白胆固醇的口服小分子药物苯哌多酸，公司总部位于密歇根州安娜堡，目前核心研发管线围绕这款降脂创新药物推进，深耕血脂异常治疗领域的创新药物开发。
Kodiak Gas Services是北美知名的天然气压缩服务供应商，主要服务油气行业上下游客户，提供定制化压缩设备、运维及运营支持，帮助客户优化陆上天然气收集、处理与运输全流程的运营效率。
ESPR vs KGS — 直观对比
营收规模更大
KGS
是对方的2.0倍
$168.4M
营收增速更快
ESPR
高出136.2%
7.5%
两年增速更快
KGS
近两年复合增速
10.6%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $168.4M | $332.9M |
| 净利润 | — | $24.6M |
| 毛利率 | — | — |
| 营业利润率 | 50.6% | 26.1% |
| 净利率 | — | 7.4% |
| 营收同比 | 143.7% | 7.5% |
| 净利润同比 | — | 29.0% |
| 每股收益（稀释后） | $0.32 | $0.30 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ESPRKGS
| Q4 25 | $168.4M | $332.9M | ||
| Q3 25 | $87.3M | $322.7M | ||
| Q2 25 | $82.4M | $322.8M | ||
| Q1 25 | $65.0M | $329.6M | ||
| Q4 24 | $69.1M | $309.5M | ||
| Q3 24 | $51.6M | $324.6M | ||
| Q2 24 | $73.8M | $309.7M | ||
| Q1 24 | $137.7M | $215.5M |
净利润ESPRKGS
| Q4 25 | — | $24.6M | ||
| Q3 25 | $-31.3M | $-14.0M | ||
| Q2 25 | $-12.7M | $39.5M | ||
| Q1 25 | $-40.5M | $30.4M | ||
| Q4 24 | — | $19.1M | ||
| Q3 24 | $-29.5M | $-5.6M | ||
| Q2 24 | $-61.9M | $6.2M | ||
| Q1 24 | $61.0M | $30.2M |
毛利率ESPRKGS
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 37.5% | ||
| Q2 24 | — | 36.5% | ||
| Q1 24 | — | 39.4% |
营业利润率ESPRKGS
| Q4 25 | 50.6% | 26.1% | ||
| Q3 25 | -11.4% | 19.9% | ||
| Q2 25 | 8.6% | 30.9% | ||
| Q1 25 | -34.0% | 27.1% | ||
| Q4 24 | -6.4% | 22.3% | ||
| Q3 24 | -31.0% | 20.4% | ||
| Q2 24 | 3.5% | 17.5% | ||
| Q1 24 | 52.5% | 27.9% |
净利率ESPRKGS
| Q4 25 | — | 7.4% | ||
| Q3 25 | -35.9% | -4.3% | ||
| Q2 25 | -15.4% | 12.2% | ||
| Q1 25 | -62.2% | 9.2% | ||
| Q4 24 | — | 6.2% | ||
| Q3 24 | -57.2% | -1.7% | ||
| Q2 24 | -83.9% | 2.0% | ||
| Q1 24 | 44.3% | 14.0% |
每股收益（稀释后）ESPRKGS
| Q4 25 | $0.32 | $0.30 | ||
| Q3 25 | $-0.16 | $-0.17 | ||
| Q2 25 | $-0.06 | $0.43 | ||
| Q1 25 | $-0.21 | $0.33 | ||
| Q4 24 | $-0.14 | $0.18 | ||
| Q3 24 | $-0.15 | $-0.07 | ||
| Q2 24 | $-0.33 | $0.06 | ||
| Q1 24 | $0.34 | $0.39 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $167.9M | $3.2M |
| 总债务越低越好 | — | $2.6B |
| 股东权益账面价值 | $-302.0M | $1.2B |
| 总资产 | $465.9M | $4.3B |
| 负债/权益比越低杠杆越低 | — | 2.12× |
8季度趋势，按日历期对齐
现金及短期投资ESPRKGS
| Q4 25 | $167.9M | $3.2M | ||
| Q3 25 | $92.4M | $724.0K | ||
| Q2 25 | $86.1M | $5.4M | ||
| Q1 25 | $114.6M | $1.9M | ||
| Q4 24 | $144.8M | $4.8M | ||
| Q3 24 | $144.7M | $7.4M | ||
| Q2 24 | $189.3M | $3.9M | ||
| Q1 24 | $226.6M | $9.3M |
总债务ESPRKGS
| Q4 25 | — | $2.6B | ||
| Q3 25 | — | $2.6B | ||
| Q2 25 | — | $2.5B | ||
| Q1 25 | — | $2.6B | ||
| Q4 24 | — | $2.6B | ||
| Q3 24 | — | $2.6B | ||
| Q2 24 | — | $2.5B | ||
| Q1 24 | — | — |
股东权益ESPRKGS
| Q4 25 | $-302.0M | $1.2B | ||
| Q3 25 | $-451.4M | $1.3B | ||
| Q2 25 | $-433.5M | $1.3B | ||
| Q1 25 | $-426.2M | $1.4B | ||
| Q4 24 | $-388.7M | $1.4B | ||
| Q3 24 | $-370.2M | $1.4B | ||
| Q2 24 | $-344.2M | $1.5B | ||
| Q1 24 | $-294.3M | $1.1B |
总资产ESPRKGS
| Q4 25 | $465.9M | $4.3B | ||
| Q3 25 | $364.0M | $4.4B | ||
| Q2 25 | $347.1M | $4.4B | ||
| Q1 25 | $324.0M | $4.4B | ||
| Q4 24 | $343.8M | $4.4B | ||
| Q3 24 | $314.1M | $4.5B | ||
| Q2 24 | $352.3M | $4.4B | ||
| Q1 24 | $373.1M | $3.3B |
负债/权益比ESPRKGS
| Q4 25 | — | 2.12× | ||
| Q3 25 | — | 2.08× | ||
| Q2 25 | — | 1.89× | ||
| Q1 25 | — | 1.91× | ||
| Q4 24 | — | 1.88× | ||
| Q3 24 | — | 1.86× | ||
| Q2 24 | — | 1.71× | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $45.2M | $194.9M |
| 自由现金流经营现金流 - 资本支出 | — | $142.0M |
| 自由现金流率自由现金流/营收 | — | 42.7% |
| 资本支出强度资本支出/营收 | 0.0% | 15.9% |
| 现金转化率经营现金流/净利润 | — | 7.91× |
| 过去12个月自由现金流最近4个季度 | — | $284.3M |
8季度趋势，按日历期对齐
经营现金流ESPRKGS
| Q4 25 | $45.2M | $194.9M | ||
| Q3 25 | $-4.3M | $113.4M | ||
| Q2 25 | $-31.4M | $177.2M | ||
| Q1 25 | $-22.6M | $114.3M | ||
| Q4 24 | $-35.0M | $118.5M | ||
| Q3 24 | $-35.3M | $36.9M | ||
| Q2 24 | $-7.2M | $121.1M | ||
| Q1 24 | $53.8M | $51.5M |
自由现金流ESPRKGS
| Q4 25 | — | $142.0M | ||
| Q3 25 | — | $10.9M | ||
| Q2 25 | — | $94.6M | ||
| Q1 25 | — | $36.8M | ||
| Q4 24 | — | $45.2M | ||
| Q3 24 | $-35.5M | $-49.7M | ||
| Q2 24 | $-7.3M | $4.0M | ||
| Q1 24 | $53.8M | $-8.6M |
自由现金流率ESPRKGS
| Q4 25 | — | 42.7% | ||
| Q3 25 | — | 3.4% | ||
| Q2 25 | — | 29.3% | ||
| Q1 25 | — | 11.2% | ||
| Q4 24 | — | 14.6% | ||
| Q3 24 | -68.7% | -15.3% | ||
| Q2 24 | -9.9% | 1.3% | ||
| Q1 24 | 39.0% | -4.0% |
资本支出强度ESPRKGS
| Q4 25 | 0.0% | 15.9% | ||
| Q3 25 | 0.0% | 31.7% | ||
| Q2 25 | 0.0% | 25.6% | ||
| Q1 25 | 0.0% | 23.5% | ||
| Q4 24 | 0.0% | 23.7% | ||
| Q3 24 | 0.3% | 26.7% | ||
| Q2 24 | 0.1% | 37.8% | ||
| Q1 24 | 0.1% | 27.9% |
现金转化率ESPRKGS
| Q4 25 | — | 7.91× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 4.49× | ||
| Q1 25 | — | 3.76× | ||
| Q4 24 | — | 6.21× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 19.44× | ||
| Q1 24 | 0.88× | 1.70× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ESPR
| Collaboration Revenue | $124.7M | 74% |
| Products | $43.7M | 26% |
KGS
| Other Services | $126.8M | 38% |
| Other | $112.2M | 34% |
| Transferred At Point In Time | $93.8M | 28% |
